← Back to Search

no additional information for Fetal Macrosomia

N/A

Recruiting

Led By Kristen Cagino, MD

Research Sponsored by The University of Texas Health Science Center, Houston

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediately after intervention (about 5 minutes after intervention)

Awards & highlights

Study Summary

"This trial aims to see if using a visual education tool can help patients understand macrosomia better. Patients will be surveyed to assess their knowledge before and 1-2 weeks after using the tool."

Who is the study for?

This trial is for individuals who are currently pregnant and may be facing a condition called fetal macrosomia, where the baby is larger than average. The study aims to see if an educational tool can help them understand this condition better.Check my eligibility

What is being tested?

The trial is testing the effectiveness of a graphic-based education tool designed to improve patient knowledge about fetal macrosomia. Participants will complete surveys to assess their understanding immediately and 1-2 weeks after using the tool.See study design

What are the potential side effects?

Since this trial involves an educational intervention rather than a medical treatment, there are no direct physical side effects expected from participating in this study.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ immediately after intervention (about 5 minutes after intervention)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~immediately after intervention (about 5 minutes after intervention)

This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after intervention (about 5 minutes after intervention) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of participants that showed Macrosomia knowledge greater than 50 percent as assessed by the score on a survey

Trial Design

2Treatment groups

Experimental Treatment

Group I: no additional informationExperimental Treatment1 Intervention

Group II: education toolExperimental Treatment1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor

904 Previous Clinical Trials

320,784 Total Patients Enrolled

2 Trials studying Fetal Macrosomia

Kristen Cagino, MDPrincipal InvestigatorThe University of Texas Health Science Center, Houston

1 Previous Clinical Trials

540 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current number of participants involved in this research trial?

"Yes, the details on clinicaltrials.gov state that this trial is currently seeking volunteers. Initially shared on January 30th, 2024, and last revised on February 20th, 2024, it aims to enroll a total of 176 participants from one site."

Answered by AI

Is the study open to individuals younger than 70 years of age?

"Eligible participants for this research must be over 18 years old but under the age of 55."

Answered by AI

Are there any ongoing efforts to enlist additional participants for this medical study?

"Indeed, information on clinicaltrials.gov confirms the ongoing recruitment of participants for this medical trial. The trial was first listed on 1/30/2024 and last revised on 2/20/2024. A total of 176 individuals are sought from a single designated site."

Answered by AI

Which individuals meet the criteria to participate in this research study?

"To qualify for participation in this study, individuals must have fetal macrosomia and fall between the ages of 18 to 55. The trial aims to recruit a total of 176 eligible candidates."

Answered by AI